TNF and COVID-19: Soluble TNF-R1 and sTNF-R2 act as decoy receptors for TNF-α (37); as such, patients with COVID-19 might be less capable of balancing pathogenic TNF-α activities than individuals with pandemic influenza A(H1N1).